Zheng MH - Search Results

1

Telomerase: a key player in the pathogenesis of non-alcoholic fatty liver disease?

Tang LJ, Rios RS, Zhang H, Byrne CD, Targher G, Zheng MH. Tang LJ, et al. Among authors: zheng mh. Expert Rev Gastroenterol Hepatol. 2021 Jul;15(7):811-819. doi: 10.1080/17474124.2021.1903318. Epub 2021 Mar 19. Expert Rev Gastroenterol Hepatol. 2021. PMID: 33709875 Review.

2

Traditional Chinese medicines benefit to nonalcoholic fatty liver disease: a systematic review and meta-analysis.

Shi KQ, Fan YC, Liu WY, Li LF, Chen YP, Zheng MH. Shi KQ, et al. Among authors: zheng mh. Mol Biol Rep. 2012 Oct;39(10):9715-22. doi: 10.1007/s11033-012-1836-0. Epub 2012 Jun 21. Mol Biol Rep. 2012. PMID: 22718512 Review.

3

Increased risk of colorectal malignant neoplasm in patients with nonalcoholic fatty liver disease: a large study.

Lin XF, Shi KQ, You J, Liu WY, Luo YW, Wu FL, Chen YP, Wong DK, Yuen MF, Zheng MH. Lin XF, et al. Among authors: zheng mh. Mol Biol Rep. 2014 May;41(5):2989-97. doi: 10.1007/s11033-014-3157-y. Epub 2014 Jan 22. Mol Biol Rep. 2014. PMID: 24449368

4

Non-alcoholic fatty liver disease and risk of in-stent restenosis after bare metal stenting in native coronary arteries.

Shi KQ, Wu FL, Liu WY, Zhao CC, Chen CX, Xie YY, Wu SJ, Lin XF, Chen YP, Wong DK, Yuen MF, Zheng MH. Shi KQ, et al. Among authors: zheng mh. Mol Biol Rep. 2014 Jul;41(7):4713-20. doi: 10.1007/s11033-014-3342-z. Epub 2014 Apr 2. Mol Biol Rep. 2014. PMID: 24691745

5

Scoring systems predict the prognosis of acute-on-chronic hepatitis B liver failure: an evidence-based review.

Wu FL, Shi KQ, Chen YP, Braddock M, Zou H, Zheng MH. Wu FL, et al. Among authors: zheng mh. Expert Rev Gastroenterol Hepatol. 2014 Aug;8(6):623-32. doi: 10.1586/17474124.2014.906899. Epub 2014 Apr 24. Expert Rev Gastroenterol Hepatol. 2014. PMID: 24762209 Review.

6

The role of fibroblast growth factor 21 in the pathogenesis of liver disease: a novel predictor and therapeutic target.

Liu WY, Huang S, Shi KQ, Zhao CC, Chen LL, Braddock M, Chen YP, Feng WK, Zheng MH. Liu WY, et al. Among authors: zheng mh. Expert Opin Ther Targets. 2014 Nov;18(11):1305-13. doi: 10.1517/14728222.2014.944898. Epub 2014 Jul 31. Expert Opin Ther Targets. 2014. PMID: 25077735 Review.

7

Increased delayed mortality in patients with acute-on-chronic liver failure who have prior decompensation.

Shi Y, Zheng MH, Yang Y, Wei W, Yang Q, Hu A, Hu Y, Wu Y, Yan H. Shi Y, et al. Among authors: zheng mh. J Gastroenterol Hepatol. 2015 Apr;30(4):712-8. doi: 10.1111/jgh.12787. J Gastroenterol Hepatol. 2015. PMID: 25250673

8

Targeting fibroblast growth factor 19 in liver disease: a potential biomarker and therapeutic target.

Liu WY, Xie DM, Zhu GQ, Huang GQ, Lin YQ, Wang LR, Shi KQ, Hu B, Braddock M, Chen YP, Zheng MH. Liu WY, et al. Among authors: zheng mh. Expert Opin Ther Targets. 2015 May;19(5):675-85. doi: 10.1517/14728222.2014.997711. Epub 2014 Dec 30. Expert Opin Ther Targets. 2015. PMID: 25547779 Review.

9

Nonalcoholic fatty liver disease: a negative risk factor for colorectal cancer prognosis.

You J, Huang S, Huang GQ, Zhu GQ, Ma RM, Liu WY, Shi KQ, Guo GL, Chen YP, Braddock M, Zheng MH. You J, et al. Among authors: zheng mh. Medicine (Baltimore). 2015 Feb;94(5):e479. doi: 10.1097/MD.0000000000000479. Medicine (Baltimore). 2015. PMID: 25654388 Free PMC article.

10

Autophagy in ethanol-exposed liver disease.

Wang LR, Zhu GQ, Shi KQ, Braddock M, Zheng MH. Wang LR, et al. Among authors: zheng mh. Expert Rev Gastroenterol Hepatol. 2015;9(8):1031-7. doi: 10.1586/17474124.2015.1052065. Expert Rev Gastroenterol Hepatol. 2015. PMID: 26186640 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

755 results

Search Page